ArticleTherapeutic innovation & regulatory science2025
Pharmaceutical Company's Choices of Indication for the First Clinical Projects in Oncological Drug Development in the United States.
Can Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it